Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions.
about
Synergy and antagonism of combinations with quinolonesIn vitro activity of daptomycin against Enterococcus faecalis under various conditions of growth-phases, inoculum and pHZingerone suppresses liver inflammation induced by antibiotic mediated endotoxemia through down regulating hepatic mRNA expression of inflammatory markers in Pseudomonas aeruginosa peritonitis mouse modelBactericidal activity of ciprofloxacin compared with that of cefotaxime in normal volunteers.In vivo bactericidal activities of ciprofloxacin and pefloxacin in an experimental model of Serratia marcescens endocarditis.Bactericidal activity and postantibiotic effect of levofloxacin against anaerobes.Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague.Randomized double blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia.Comparison of the chemistry and diversity of endophytes isolated from wild-harvested and greenhouse-cultivated yerba mansa (Anemopsis californica).Comparative efficacies of ciprofloxacin and pefloxacin alone or in combination with fosfomycin in experimental endocarditis induced by multidrug-susceptible and -resistant Pseudomonas aeruginosa.In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa.Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosaIn vitro synergism between cefotaxime and minocycline against Vibrio vulnificus.Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospitalSynergism of the combinations of imipenem plus ciprofloxacin and imipenem plus amikacin against Pseudomonas aeruginosa and other bacterial pathogens.Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria.Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic ratsNitrite reductase from Pseudomonas aeruginosa induces inflammatory cytokines in cultured respiratory cells.Effect of clavulanic acid on the activity of ticarcillin against Pseudomonas aeruginosa.Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies.Infective Endocarditis of the Aortic Valve caused by Pseudomonas aeruginosa and Treated Medically in a Patient on Haemodialysis.Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.The mode of action of quinolones: the paradox in activity of low and high concentrations and activity in the anaerobic environment.Ofloxacin versus parenteral therapy for chronic osteomyelitisCiprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised studyIn Vitro Antibacterial Activity of three Indian Spices Against Methicillin-Resistant Staphylococcus aureus.Use of pharmacodynamic indices to predict efficacy of combination therapy in vivo.Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules.In vitro activity of ciprofloxacin in combination with ceftazidime, aztreonam, and azlocillin against multiresistant isolates of Pseudomonas aeruginosa.Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations.Ciprofloxacin interactions with imipenem and amikacin against multiresistant Pseudomonas aeruginosa.The importance of lag time extension in determining bacterial resistance to antibiotics.Proton Nuclear Magnetic Resonance Spectroscopy as a Technique for Gentamicin Drug Susceptibility Studies with Escherichia coli ATCC 25922.Nanocapsules loaded with iron-saturated bovine lactoferrin have antimicrobial therapeutic potential and maintain calcium, zinc and iron metabolism.Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.Ciprofloxacin treatment of bacterial endocarditis involving prosthetic material after cardiac surgery.Anticariogenic and Hemolytic Activity of Selected Seed Protein Extracts In vitro conditionsInvestigating the effect of antibiotics on quorum sensing with whole-cell biosensing systems.Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis.
P2860
Q28327424-F2294D6D-E64B-4C7A-AB6E-D4BEED27BD2EQ28488311-7B361981-872A-4515-AA14-EB8B97E77B19Q28542902-98C2E69D-6639-470A-AE42-E0C570ACC19DQ30451758-11215A19-6C8E-44D2-85B5-60C08086BEB0Q33753649-7DB73598-DABD-4D4A-BDE1-4F5894B719E0Q33977925-9B36F676-AC64-4B52-A874-E3B94ED32901Q34534012-FCAB4E34-BB3B-40B3-B028-60C7BBC50EF5Q34583481-3FC62EB2-E7D0-45B7-9C65-AC02B0ED376EQ35015625-9A3AA30C-7A11-47F8-B0E9-ADF2C488BD6CQ35111825-E4C2D7F8-E6C8-430F-974C-F0A10101197DQ35117021-A1D7514C-6B26-420A-9525-C51DB7692C82Q35120290-53D72870-F98F-40F3-B089-D7B6D5BEC2F0Q35138554-D395A81D-31DB-4E59-92A2-F963504B8FEFQ35291821-D2919E14-0F8F-4623-9972-9E190D8C8689Q35329548-2E9C648E-6B84-4F66-A753-132FD7CB945BQ35539176-AE734357-F872-4649-957C-CCBE63A398CDQ35541583-72DC3284-7934-452E-94B6-E3C90897D544Q35543546-ED2494B1-B4C8-409F-B2A0-2C5C503972F2Q35550634-13CD1A24-F974-4903-AB1A-DFA39C960502Q35575219-F8DC264B-1DDD-46E8-AF87-24AE99BAAB8FQ35653503-BABE9D31-75DF-4E8C-8A19-9EC8F9823775Q35778204-18FF31C6-DCE8-40C0-BA9C-46D625C94981Q35814807-A3445D4C-2D65-474C-B125-43D3D3BD5337Q36670132-17854F96-F2CE-45BB-A6AB-E174236F68D3Q36753143-9D23957E-47E9-4C42-AD55-E2718B412542Q36805904-F158697C-6539-4675-AFFC-0EFB83FC9452Q39088189-AAFCB4A3-29F4-499D-BABE-6AC67D3F4D11Q39471967-76D555DD-4D65-4FA1-B53F-5AD1C5F9E41BQ39607491-A32D2126-7AA6-43F6-8688-E6BB3153F50AQ39816839-DD9CD0ED-9DD2-4649-BA71-664271E57C41Q39819729-AA03CDFC-F817-47AA-B23D-AF622EA3EA6AQ40283892-725C1012-062B-4434-B3C1-F485CEC55E92Q40715166-FA6770E1-8D5F-4134-B3BA-06C070BCA520Q41233351-EE6172A7-DCCB-446E-940F-FEA3A721A495Q41639218-216C8713-8E14-4229-A3D7-F76D22809FE2Q41810184-2E22F954-48C0-4262-8977-F49A6ABE3972Q41883787-7537C6ED-929F-4DD2-8CFE-0E98613A567FQ41903276-F654BEF6-1A7D-4A29-B099-8CA7848935B3Q44936475-B3BB9684-9D1A-481D-8FBB-6E59A73305AAQ54131581-3A62E816-7EE2-42D1-BBB6-E7721D0D3FF2
P2860
Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Antimicrobial activity of cipr ...... and synergistic interactions.
@ast
Antimicrobial activity of cipr ...... and synergistic interactions.
@en
type
label
Antimicrobial activity of cipr ...... and synergistic interactions.
@ast
Antimicrobial activity of cipr ...... and synergistic interactions.
@en
prefLabel
Antimicrobial activity of cipr ...... and synergistic interactions.
@ast
Antimicrobial activity of cipr ...... and synergistic interactions.
@en
P2860
P356
P1476
Antimicrobial activity of cipr ...... and synergistic interactions.
@en
P2093
Chalkley LJ
Koornhof HJ
P2860
P304
P356
10.1128/AAC.28.2.331
P407
P577
1985-08-01T00:00:00Z